Cirrhosis and multiple organ damage
Keywords:
Liver cirrhosis, Multiple organ damage, healthAbstract
Chronic and progressive cirrhosis of the liver, which can have many different causes, is distinguished by excessive fibrosis of liver tissue and changes in lobular architecture. Chronic inflammation, oxidative stress, and mitochondrial dysfunction are linked in a negative feedback loop that develops as cirrhosis worsens, eventually resulting in cell damage and hepatocellular death. The term "multi-organ dysfunction syndrome in cirrhosis" (MODS) was created as evidence for the involvement of organs other than the liver in cirrhotic patients. Due to the dysfunctional release of inflammatory, endothelial, and coagulation mediators by the liver, bacterial translocation, and the immune response, this syndrome involves a number of changes in systems, including the renal, cardiovascular, pulmonary, and brain systems, among others. others. The morbidity and mortality of patients with cirrhosis are significantly affected by multi-organ dysfunction, which also affects quality of life, complicates liver transplant evaluation, increases the risk of surgery, and increases surgical risk. The clinical management and quality of life of people with cirrhosis will improve with a deeper understanding of the interactions between the various organs and systems.
Keywords: Liver cirrhosis, Multiple organ damage, health.
Downloads
References
Boboš, Marina & Nenadic, Irina & Djuric, Marko & Vukotic, Aleksandra & Culjic, Radmila & Stevanovic, Predrag. (2022). Preoperativna priprema pacijenata sa cirozom Preoperative evaluation of patients with cirrhosis. Materia Medica. 35. 1802-1817.
Buey, L. G., Mateos, F. G., & Moreno-Otero, R. (2012). Cirrosis hepática. Medicine-Programa de formación médica continuada acreditado, 11(11), 625-633.
Fortea, J. I., Carrera, I. G., Puente, A., & Crespo, J. (2020). Cirrosis hepática. Medicine-Programa de Formación Médica Continuada Acreditado, 13(6), 297-307.
García, D. R., & Cañizares, R. B. (2016). Cirrosis hepática. Medicine: Programa de Formación Médica Continuada Acreditado, 12(11), 597-605.
Medina Lois, E., & Kaempffer Ramírez, A. M. (2002). Cirrosis hepática en Chile. Rev. chil. salud pública, 7-14.
Rakhman, Mahendra & Indriani, Vitasari & E, Dwi. (2021). CORRELATION OF ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX (APRI) WITH THE DEGREE OF SEVERITY LIVER ORGAN IN CIRRHOSIS HEPATIC PATIENTS. Mandala Of Health. 14. 16. 10.20884/1.mandala.2021.14.1.3074.
Rincón, D., & Bañares, R. (2016). Cirrosis hepática. Medicine-Programa de Formación Médica Continuada Acreditado, 12(11), 597-605.
Sakharkar, Sheetal & Gujar, Samrudhi & Tembhare, Vaishali & Wagh, Pranali & Khandar, Jaya & Shambharkar, Madhuri & Kolhekar, Sonali & Pande, Khushbu. (2021). Case Report on Cirrhosis of Liver. Journal of Pharmaceutical Research International. 171-175. 10.9734/jpri/2021/v33i52A33572.
Shchyokotova, A. (2022). Liver cirrhosis. Perm Medical Journal. 39. 41-57. 10.17816/pmj39441-57.
Tkachenko, T. & Shevchuk, S. & Masik, N. (2022). Acute decompensation of liver cirrhosis and acute-on-chronic liver failure: diagnostic and prognostic criteria, treatment strategy. Reports of Vinnytsia National Medical University. 26. 644-652. 10.31393/reports-vnmedical-2022-26(4)-22.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 BIOSANA Health Scientific Journal. ISSN 2960-8481

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




